Capricor Therapeutics, Inc. SEC filings CAPR

Capricor Therapeutics, Inc. has 963 filings in SEC EDGAR's recent list, going back to Feb 7, 2001. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 24, 2026 (other events). The company's fiscal year ends on December 31.

Capricor Therapeutics, Inc. SEC filings
Form Description Filed Period
ARS Annual report to shareholders Apr 10, 2026 Dec 31, 2025
10-K Annual report Mar 17, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 9, 2025 Dec 31, 2024
10-K Annual report Mar 26, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 1, 2024 Dec 31, 2023
10-K Annual report Mar 11, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 21, 2023 Dec 31, 2022
10-K Annual report Mar 17, 2023 Dec 31, 2022
10-K Annual report Mar 11, 2022 Dec 31, 2021
10-K Annual report Mar 15, 2021 Dec 31, 2020
10-K Annual report Mar 27, 2020 Dec 31, 2019
10-K/A Amended annual report Apr 1, 2019 Dec 31, 2018
10-K Annual report Mar 29, 2019 Dec 31, 2018
10-K Annual report Mar 22, 2018 Dec 31, 2017
10-K Annual report Mar 16, 2017 Dec 31, 2016
10-K Annual report Mar 30, 2016 Dec 31, 2015
10-K Annual report Mar 16, 2015 Dec 31, 2014
ARS Annual report to shareholders Sep 24, 2014 Dec 31, 2013
10-K Annual report Mar 31, 2014 Dec 31, 2013
10-K Annual report Jun 21, 2013 Dec 31, 2012
10-K Annual report Apr 2, 2012 Dec 31, 2011
10-K Annual report Mar 14, 2011 Dec 31, 2010
10-K Annual report Mar 3, 2010 Dec 31, 2009
10-K/A Amended annual report Apr 23, 2009 Dec 31, 2008
10-K Annual report Mar 12, 2009 Dec 31, 2008

Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CAPR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1133869
Former names
Nile Therapeutics, Inc. (until Nov 20, 2013); SMI PRODUCTS INC (until Sep 19, 2007)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.